APJ News

VVMF selects SYSPRO Cloud ERP to advance cell and gene therapy manufacturing

VVMF

Australia’s first viral vector CDMO adopts SYSPRO’s Cloud ERP to enhance traceability, quality management, and regulatory compliance.

Sydney-based Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO), has chosen SYSPRO Cloud ERP to support its growth and manufacturing operations. Located within the Westmead Health and Innovation Precinct, VVMF focuses on the design, development, and production of viral vectors critical to treating cancer and rare diseases.

“Integrating SYSPRO Cloud ERP ensures we meet the highest standards for quality, compliance, and patient safety,” says Daniel Clampett, COO of VVMF.

SYSPRO’s system will deliver embedded analytics, financials, manufacturing and distribution capabilities, lot traceability, quality management, and materials planning. These functions are essential to VVMF’s mission to uphold the strict standards of the Therapeutic Goods Administration (TGA) and global health regulators.

By implementing SYSPRO’s ERP early in its journey, VVMF ensures it can scale efficiently, maintain product integrity, and accelerate the path to market for critical therapies.

Related posts

World Economic Forum Highlights Growing Supply Chain Cyber Threats in Global Cybersecurity Outlook 2025

enterpriseitworld

UK Unveils Cyber Security and Resilience Bill to Protect Critical Infrastructure and National Economy

enterpriseitworld

Graphwise Launches AI-Driven Knowledge Graph Solution for Microsoft 365 to Tackle Content Sprawl and Drive Productivity

enterpriseitworld